333

GENMONT BIOTECH INC

No trades
See on Supercharts
Market capitalization
‪1.92 B‬TWD
‪32.99 M‬TWD
‪318.02 M‬TWD
‪80.52 M‬
Beta (1Y)
0.42

About GENMONT BIOTECH INC

CEO
Yu Chin Chen
Headquarters
Tainan
Founded
2000
ISIN
TW0003164000
FIGI
BBG000D1J038
Genmont Biotech Inc. engages in the research development, manufacturing, and selling of probiotic supplements. It operates through the GenMont and GenMont(China) segments. The company was founded on January 3, 2000 and is headquartered in Tainan, Taiwan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 3164 is 22.10 TWD — it has decreased by 0.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange GENMONT BIOTECH INC stocks are traded under the ticker 3164.
GENMONT BIOTECH INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
3164 stock is 2.52% volatile and has beta coefficient of 0.42. Check out the list of the most volatile stocks — is GENMONT BIOTECH INC there?
Yes, you can track GENMONT BIOTECH INC financials in yearly and quarterly reports right on TradingView.
3164 stock has fallen by 2.43% compared to the previous week, the month change is a 2.00% fall, over the last year GENMONT BIOTECH INC has showed a 12.30% decrease.
3164 net income for the last quarter is ‪−2.02 M‬ TWD, while the quarter before that showed ‪23.88 M‬ TWD of net income which accounts for −108.44% change. Track more GENMONT BIOTECH INC financial stats to get the full picture.
Today GENMONT BIOTECH INC has the market capitalization of ‪1.92 B‬, it has increased by 4.16% over the last week.
Yes, 3164 dividends are paid annually. The last dividend per share was 0.70 TWD. As of today, Dividend Yield (TTM)% is 3.15%. Tracking GENMONT BIOTECH INC dividends might help you take more informed decisions.
GENMONT BIOTECH INC dividend yield was 2.02% in 2023, and payout ratio reached 130.96%. The year before the numbers were 2.95% and 106.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 3164 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENMONT BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
3164 reached its all-time high on Jan 18, 2011 with the price of 113.20 TWD, and its all-time low was 16.20 TWD and was reached on Mar 23, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENMONT BIOTECH INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENMONT BIOTECH INC stock shows the sell signal. See more of GENMONT BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENMONT BIOTECH INC EBITDA is ‪71.77 M‬ TWD, and current EBITDA margin is 22.57%. See more stats in GENMONT BIOTECH INC financial statements.